EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exosomes in Alzheimer’s disease: neuroinflammation mitigation via immune modulation and inflammatory pathway targeting

Hongtao Jia, Yonghai Meng, Nan Zhao, Yan Liu

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-11780-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 16.04.2026. Verfasst von Hongtao Jia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Heilongjiang University of Chinese Medicine, Harbin, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Exosomes, Neuroinflammatory Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: Natural Science Foundation of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) progression is tightly linked to neuroinflammation driven by central-peripheral immune imbalance, with microglial/astrocytic activation, blood-brain barrier disruption, and cytokine dysregulation forming a vicious cycle. Exosomes, as nanoscale extracellular vesicles, emerge as potent modulators by crossing the blood-brain barrier and delivering functional cargos (miR-146a, miR-124, TREM2, IL-10) to target immune and neuronal cells. They induce M2 microglial polarization, inhibit A1 astrocyte transformation, and balance Treg/Th17 subsets, while suppressing NF-κB and NLRP3 inflammasome pathways to reduce pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) and elevate anti-inflammatory IL-10. Additionally, exosomes enhance Aβ/tau clearance via promoting phagocytosis and autophagy, and repair the blood-brain barrier to mitigate peripheral immune infiltration. Derived from MSCs, immune cells, or traditional Chinese medicines, exosomes exhibit low immunogenicity and high biocompatibility, with preclinical and pilot clinical data confirming 30%–50% improvement in cognitive scores and 40%–60% reductions in cerebrospinal fluid IL-1β, TNF-α, and IL-6 levels in AD models and patients. These findings highlight exosomes as a multitargeted strategy to ameliorate neuroinflammation and halt AD neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseExosomesNeuroinflammatory DiseasesHumansAnimalsBlood-Brain BarrierCytokinesInflammationMicrogliaImmunomodulationSignal TransductionAmyloid beta-Peptides

Stichwörter der Autor:innen

Alzheimer’s diseaseCognitive impairmentExosomeImmune regulationInflammatory cytokinesNeuroinflammation

Substanzen

CytokinesAmyloid beta-Peptides

Autor:innen und Institutionen

  • Heilongjiang University of Chinese Medicine, Harbin, China.
  • Heilongjiang University of Chinese Medicine, Harbin, China. nan9507550@163.com.
  • Heilongjiang University of Chinese Medicine, Harbin, China. hljzyydxxwb@163.com.

Förderung

  • Natural Science Foundation of Heilongjiang Province

Zitieren

APA

Jia, H., Meng, Y., Zhao, N., & Liu, Y. (2026). Exosomes in Alzheimer’s disease: neuroinflammation mitigation via immune modulation and inflammatory pathway targeting. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-11780-4

Vancouver

Jia H, Meng Y, Zhao N, Liu Y. Exosomes in Alzheimer’s disease: neuroinflammation mitigation via immune modulation and inflammatory pathway targeting. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-11780-4

BibTeX
@article{Jia2026,
  author = {Jia, Hongtao and Meng, Yonghai and Zhao, Nan and Liu, Yan},
  title = {Exosomes in Alzheimer’s disease: neuroinflammation mitigation via immune modulation and inflammatory pathway targeting},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-11780-4}
}
Kostenlos starten →